Xenon Pharmaceuticals Inc.
XENE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582313
In the last 90 days, Xenon Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 315 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q1 2025
Institutional positions in Xenon Pharmaceuticals Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 206
- −3 vs. Q4 2024
- Shares held
- 76.7M
- +410.6K (+0.5%) vs. Q4 2024
- Total value
- $2.58B
- −$414.7M (−13.9%) vs. Q4 2024
- New holders
- 20
- 69 more added
- Sold out
- 23
- 73 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XENE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 315 | $6.10B |
| Q1 2026 | 290 | $5.80B |
| Q4 2025 | 245 | $3.78B |
| Q3 2025 | 219 | $3.39B |
| Q2 2025 | 206 | $2.60B |
| Q1 2025 | 206 | $2.58B |
| Q4 2024 | 209 | $2.99B |
| Q3 2024 | 203 | $2.95B |
| Q2 2024 | 213 | $2.89B |
| Q1 2024 | 220 | $3.16B |
| Q4 2023 | 204 | $3.32B |
| Q3 2023 | 181 | $2.10B |
| Q2 2023 | 175 | $2.36B |
| Q1 2023 | 163 | $2.19B |
| Q4 2022 | 159 | $2.38B |
| Q3 2022 | 154 | $2.09B |
| Q2 2022 | 151 | $1.73B |
| Q1 2022 | 132 | $1.50B |
| Q4 2021 | 130 | $1.49B |
| Q3 2021 | 118 | $521.7M |
| Q2 2021 | 103 | $620.0M |
| Q1 2021 | 91 | $590.0M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Xenon Pharmaceuticals Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Capital International Investors | 3,088,730 | $103.6M | 0.02% | +541,520+21.3% | Added |
| Janus Henderson Group PLC | 3,325,093 | $113.9M | 0.06% | +458,338+16.0% | Added |
| Wellington Management Group LLP | 3,789,197 | $127.1M | 0.02% | +11,586+0.3% | Added |
| Driehaus Capital Management LLC | 4,584,859 | $153.8M | 1.48% | +64,264+1.4% | Added |
| Avoro Capital Advisors LLC | 5,741,666 | $192.6M | 3.01% | +75,000+1.3% | Added |
| FMR LLC | 8,287,499 | $278.0M | 0.02% | +762,209+10.1% | Added |
| Proequities, Inc. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −221,982−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −155,540−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −62,052−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −48,668−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −39,938−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −30,699−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −20,430−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −19,005−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −17,395−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −11,397−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −11,138−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −8,671−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −8,200−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −8,054−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −7,171−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −6,554−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −5,363−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −2,569−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −1,802−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Hexagon Capital Partners LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |